Vascular Aging Impact & End-Organ Surveillance Panel
Comprehensive panel evaluating cardiac strain, myocardial injury, kidney function, metabolic balance, and glycemic control. Measures NT-proBNP, high-sensitivity Troponin T, A1c, CMP, CBC, and urinary albumin to assess the systemic impact of vascular aging and cardiometabolic stress. Designed for structured end-organ surveillance and proactive cardiovascular health monitoring.
- $995.24
- $268
- Save: 73.07%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: BNP, N-terminal pro b-type natriuretic peptide, proBNP Nterminal
Probnp, N Terminal
TROPONIN T, HIGH
The Vascular Aging Impact & End-Organ Surveillance Panel panel contains 6 tests with 60 biomarkers .
Comprehensive Evaluation of Vascular Stress and End-Organ Health
The Vascular Aging Impact & End-Organ Surveillance Panel is a multidimensional laboratory profile designed to assess how vascular aging and cardiometabolic stress may be affecting critical organs, including the heart, kidneys, blood vessels, and metabolic systems. Rather than focusing solely on cholesterol or isolated risk markers, this panel evaluates biomarkers associated with cardiac strain, myocardial injury, glycemic control, kidney function, liver health, and hematologic status.
Vascular aging refers to progressive changes in arterial structure and function over time, including reduced elasticity, endothelial dysfunction, and increased cardiovascular strain. These changes can influence downstream organ systems long before overt symptoms develop. This panel integrates cardiac biomarkers such as NT-proBNP and high-sensitivity Troponin T, along with metabolic and renal markers, to provide a broader perspective on systemic impact.
The panel includes:
-
Comprehensive Metabolic Panel (CMP)
-
Albumin Random Urine with Creatinine
-
Complete Blood Count (CBC) with Differential and Platelets
-
NT-proBNP
-
High-Sensitivity Troponin T
-
Hemoglobin A1c
Together, these markers help evaluate cardiac workload, early myocardial stress, microvascular integrity, glucose regulation, electrolyte balance, kidney filtration, liver enzymes, and blood cell health. This structured approach supports a proactive evaluation of end-organ health in the context of cardiovascular and metabolic risk.
By examining both cardiac-specific biomarkers and systemic indicators, this panel provides clinically meaningful insight into the broader physiological impact of vascular aging and cardiometabolic stress.
When and Why Someone Would Order This Panel
Assessing the Impact of Cardiovascular Risk Factors
This panel may be ordered when there is concern that long-standing cardiovascular risk factors—such as hypertension, diabetes, metabolic syndrome, or chronic inflammation—may be affecting organ function. Vascular aging does not occur in isolation; it influences the heart, kidneys, and microcirculation. Evaluating cardiac strain markers alongside metabolic and renal markers allows for a more comprehensive assessment of physiological impact.
Monitoring Individuals with Elevated Cardiometabolic Risk
Patients with elevated Hemoglobin A1c, abnormal lipid patterns, or a history of cardiovascular risk factors may benefit from periodic evaluation of end-organ markers. NT-proBNP and high-sensitivity Troponin T provide insight into cardiac stress and subtle myocardial injury, even in the absence of overt cardiac symptoms.
Healthcare providers may consider this panel when:
-
There is concern about early heart strain
-
Blood pressure has been difficult to control
-
Diabetes or insulin resistance is present
-
There is a need for structured surveillance of organ health
Evaluating Kidney and Microvascular Health
The Albumin Random Urine with Creatinine test detects early microalbuminuria, a potential marker of kidney stress and endothelial dysfunction. Subtle kidney changes can occur before measurable declines in filtration rate, making early detection valuable in long-term risk management.
Comprehensive Baseline for Preventive Health Monitoring
This panel may also serve as a baseline for individuals undergoing preventive cardiovascular care. By establishing objective markers of cardiac strain, glycemic control, and organ function, providers can monitor trends over time and adjust care strategies accordingly.
Overall, the panel supports proactive surveillance of organ systems that may be affected by vascular aging and chronic cardiometabolic stress.
What Does the Panel Measure
Comprehensive Metabolic Panel (CMP)
The CMP evaluates:
-
Kidney function (creatinine, blood urea nitrogen)
-
Liver enzymes (ALT, AST, alkaline phosphatase)
-
Electrolytes (sodium, potassium, chloride)
-
Blood glucose
-
Total protein and albumin
These markers provide insight into metabolic stability, hydration status, organ function, and systemic balance.
Albumin Random Urine with Creatinine
This test measures urinary albumin relative to creatinine concentration. Elevated urinary albumin may indicate early kidney damage or microvascular stress, particularly in individuals with diabetes or hypertension.
Complete Blood Count (CBC) with Differential and Platelets
The CBC evaluates:
-
Red blood cell count and hemoglobin
-
White blood cell count and differential
-
Platelet count
These markers help assess oxygen-carrying capacity, immune system activity, and clotting potential, all of which may influence vascular health.
NT-proBNP
NT-proBNP is a biomarker released by the heart in response to increased wall stress and ventricular strain. Elevated levels may indicate increased cardiac workload or changes in cardiac function.
High-Sensitivity Troponin T
High-sensitivity Troponin T detects very small amounts of cardiac muscle injury. Even subtle elevations may reflect low-grade myocardial stress or injury and can provide insight into ongoing cardiac strain.
Hemoglobin A1c
Hemoglobin A1c reflects average blood glucose levels over approximately three months. Persistent elevations are associated with increased risk of vascular damage and microvascular complications.
How Patients and Healthcare Providers Use the Results
Detecting Early Cardiac Strain
Elevated NT-proBNP levels may indicate increased cardiac wall stress, which can be associated with heart failure risk or structural cardiac changes. High-sensitivity Troponin T may detect subtle myocardial injury before overt clinical symptoms develop. Together, these markers support early identification of cardiac stress.
Monitoring Glycemic and Microvascular Risk
Hemoglobin A1c levels help assess long-term glucose regulation. Elevated A1c is associated with increased risk of coronary artery disease, peripheral vascular disease, and diabetic nephropathy. Urinary albumin measurements can detect early kidney involvement and microvascular damage.
Evaluating Organ Function
The CMP provides insight into kidney and liver function, electrolyte balance, and metabolic stability. Abnormal results may guide further evaluation or monitoring strategies.
Assessing Hematologic and Inflammatory Influences
The CBC can identify anemia, abnormal platelet counts, or changes in white blood cell distribution that may influence cardiovascular risk or systemic inflammation.
Supporting Longitudinal Surveillance
This panel is particularly valuable when used over time. Trends in NT-proBNP, Troponin T, A1c, and urinary albumin can help assess the impact of blood pressure control, metabolic management, and lifestyle modifications on organ health.
Conditions that may be evaluated or monitored with components of this panel include:
-
Heart failure
-
Coronary artery disease
-
Hypertensive heart disease
-
Diabetic nephropathy
-
Chronic kidney disease
-
Cardiometabolic syndrome
Results are interpreted within clinical context to support informed medical decision-making.
A Proactive Approach to Vascular and Organ Health
The Vascular Aging Impact & End-Organ Surveillance Panel offers a comprehensive evaluation of how cardiovascular and metabolic stress may be affecting critical organ systems. By integrating cardiac biomarkers, metabolic markers, kidney surveillance, and hematologic testing, this panel provides a structured assessment of systemic impact.
Vascular aging can influence the heart, kidneys, and microcirculation long before significant symptoms develop. Early detection of changes in cardiac strain, glycemic control, or kidney function supports timely and personalized care strategies.
Used as part of a broader preventive or monitoring plan, this panel helps provide clarity regarding end-organ health and supports evidence-based decisions aimed at preserving long-term cardiovascular and metabolic well-being.